Tzu-Hsuan Huang

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Venues

Communications medicine

PloS one

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Lauren R Begg, Adrienne M Orriols, Markella Zannikou, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia, Rosemary Bolin, Sara F Dunne, Sanjeev Balakrishnan, Roman Camarda, Diane Roth, Nicolette A Zielinski-Mozny, Christina Yau, Athanassios Vassilopoulos, Tzu-Hsuan Huang, Kwang-Youn A Kim, Dai Horiuchi
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models. Communications medicine 4 (1) (2024)
Lauren R Begg, Adrienne M Orriols, Markella Zannikou, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia, Rosemary Bolin, Sara F Dunne, Sanjeev Balakrishnan, Roman Camarda, Diane Roth, Nicolette A Zielinski-Mozny, Christina Yau, Athanassios Vassilopoulos, Tzu-Hsuan Huang, Kwang-Youn A Kim, Dai Horiuchi
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models. Communications medicine 4 (1) (2024)
Lauren R Begg, Adrienne M Orriols, Markella Zannikou, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia, Rosemary Bolin, Sara F Dunne, Sanjeev Balakrishnan, Roman Camarda, Diane Roth, Nicolette A Zielinski-Mozny, Christina Yau, Athanassios Vassilopoulos, Tzu-Hsuan Huang, Kwang-Youn A Kim, Dai Horiuchi
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models. Communications medicine 4 (1) (2024)
Lauren R Begg, Adrienne M Orriols, Markella Zannikou, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia, Rosemary Bolin, Sara F Dunne, Sanjeev Balakrishnan, Roman Camarda, Diane Roth, Nicolette A Zielinski-Mozny, Christina Yau, Athanassios Vassilopoulos, Tzu-Hsuan Huang, Kwang-Youn A Kim, Dai Horiuchi
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models. Communications medicine 4 (1) (2024)
Lauren R Begg, Adrienne M Orriols, Markella Zannikou, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia, Rosemary Bolin, Sara F Dunne, Sanjeev Balakrishnan, Roman Camarda, Diane Roth, Nicolette A Zielinski-Mozny, Christina Yau, Athanassios Vassilopoulos, Tzu-Hsuan Huang, Kwang-Youn A Kim, Dai Horiuchi
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models. Communications medicine 4 (1) (2024)
Anders Malarstig, Felix Grassmann, Leo Dahl, Marios Dimitriou, Dianna McLeod, Marike Gabrielson, Karl Smith-Byrne, Cecilia Engel Thomas, Tzu-Hsuan Huang, Simon K G Forsberg, Per Eriksson, Mikael Ulfstedt, Mattias Johansson, Aleksandr V Sokolov, Helgi B Schiöth, Per Hall, Jochen M Schwenk, Kamila Czene, Åsa K Hedman
Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation. Nature communications 14 (1) (2023)
Jun Guo, Yu Xiao, Ramesh Iyer, Xin Lu, Marc Lake, Uri Ladror, John Harlan, Tanushree Samanta, Medha Tomlinson, Gail Bukofzer, Cherrie Donawho, Alex Shoemaker, Tzu-Hsuan Huang
Empowering therapeutic antibodies with IFN-α for cancer immunotherapy. PloS one 14 (8) (2019)

Tzu-Hsuan Huang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tzu-Hsuan Huang